Zhaoke Ophthalmology Ltd 2020 SR
The report highlights Zhaoke Ophthalmology's first ESG disclosure following its listing on the Hong Kong Stock Exchange. The company established a sustainability steering committee to oversee ESG initiatives and identified key material issues like product quality and business ethics. In 2020, the Group focused on building its drug pipeline for major ophthalmic indications and maintaining a commercial-scale manufacturing facility in Nansha. Environmental efforts included quantifying greenhouse gas emissions and implementing energy-saving measures. The Group also emphasized employee development and safety, reporting zero work-related fatalities.
Company: Zhaoke Ophthalmology Ltd
Sector: Health Care
Country: China
Year: 2020
Type: SR
Pages: 38
Zhaoke Ophthalmology Ltd
ESG Report
The report highlights Zhaoke Ophthalmology's first ESG disclosure following its listing on the Hong Kong Stock Exchange. The company established a sustainability steering committee to oversee ESG initiatives and identified key material issues like product quality and business ethics. In 2020, the Group focused on building its drug pipeline for major ophthalmic indications and maintaining a commercial-scale manufacturing facility in Nansha. Environmental efforts included quantifying greenhouse gas emissions and implementing energy-saving measures. The Group also emphasized employee development and safety, reporting zero work-related fatalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Jul 27, 2021
Type
Sustainability Report
Language
English, Chinese
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees